Published in Clin Ther on December 30, 1997
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly. Gastroenterol Clin North Am (2015) 0.87
Helicobacter pylori. Postgrad Med J (2000) 0.75
Pelvic floor study in patients with obstructive defecation: influence of biofeedback. J Clin Gastroenterol (2000) 1.56
Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. Eur J Clin Nutr (2006) 1.51
ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect (1991) 1.30
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. Aliment Pharmacol Ther (1997) 1.25
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect (2002) 1.09
Diagnosis of Helicobacter pylori infection by HpSA test. Lancet (1999) 1.03
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. J Intern Med (1998) 1.00
Clindamycin-associated colitis: report of a case. Dis Colon Rectum (1975) 0.98
The use of ERCP in the study of patients with hepatic echinococcosis before and after surgical intervention. Gastrointest Endosc (1996) 0.97
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance. Gynecol Oncol (2007) 0.96
Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Cancer Res (2001) 0.94
Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns. Gut (1996) 0.94
Ranitidine versus ranitidine plus octreotide in the treatment of acute non-variceal upper gastrointestinal bleeding: a prospective randomised study. Curr Med Res Opin (2000) 0.92
Image of the month. Histoacryl-lipiodol embolization to the lung. Gastroenterology (2001) 0.92
B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease? Am J Gastroenterol (2001) 0.92
The Gm and Inv factors in rheumatoid arthritis. Acta Genet Med Gemellol (Roma) (1975) 0.92
Colonic findings in cirrhotics with portal hypertension. A prospective colonoscopic and histological study. J Clin Gastroenterol (1994) 0.92
Mucosal hyperplastic polyps of the stomach. Do they have any potential to malignancy? Pathol Res Pract (1986) 0.91
Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma. Acta Hepatogastroenterol (Stuttg) (1976) 0.90
Seroepidemiology of Helicobacter pylori infection in Greece. FEMS Microbiol Immunol (1990) 0.89
The incidence of gallstones in Greece; an autopsy study. Acta Hepatogastroenterol (Stuttg) (1977) 0.88
Chronic granulocytic leukemia in a patient with ankylosing spondylitis and ulcerative colitis: an interesting association. J Clin Gastroenterol (1997) 0.87
[Alveolar echinococcosis of the liver. 3 observations in Greece]. Nouv Presse Med (1978) 0.86
Letter: Australia antigen and malignant hepatoma. Ann Intern Med (1975) 0.84
Stenosis of the colon secondary to pancreatitis: report of a case. Dis Colon Rectum (1975) 0.83
Leptin alterations in the course of sepsis in humans. In Vivo (2006) 0.83
Survivin expression in colorectal carcinomas: correlations with clinicopathological parameters and survival. Dig Dis Sci (2009) 0.82
Helicobacter pylori infection in Greece in healthy people and in patients with peptic ulcer and with dyspepsia without ulcer. J Clin Gastroenterol (1993) 0.82
Serum Gc system in liver cirrhosis and hepatoma. Hum Genet (1977) 0.81
Evidence that even "normal" albuminuria may denote incipient GFR reduction in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2009) 0.81
Serum trypsin inhibitory capacity and alpha 1-antitrypsin levels in liver cirrhosis and hepatoma. Acta Hepatogastroenterol (Stuttg) (1979) 0.80
Tuberculosis of the anal canal. J Clin Gastroenterol (1993) 0.79
Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites. Ann Med Interne (Paris) (1996) 0.79
Neural network application in the discrimination of benign from malignant gastric cells. Anal Quant Cytol Histol (2000) 0.79
The syndrome of gastric carcinoid and hyperparathyroidism: a family study and literature review. Eur J Endocrinol (2009) 0.78
Serum gastrin concentrations in healthy males and females of various ages. Acta Hepatogastroenterol (Stuttg) (1979) 0.78
Potential of the back propagation neural network in the discrimination of benign from malignant gastric cells. Anal Quant Cytol Histol (1996) 0.78
Ulcerative colitis and sarcoidosis: a curious association-report of a case. Dis Colon Rectum (1981) 0.78
Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA). Curr Med Res Opin (2010) 0.78
Significance of various factors in patients with functional dyspepsia and peptic ulcer disease in Greece. A comparative prospective study. Ann Med Interne (Paris) (1995) 0.78
Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J Clin Gastroenterol (1995) 0.77
Comparative study of cimetidine and cetraxate in the treatment of peptic ulcer. J Clin Gastroenterol (1991) 0.77
Preliminary evaluation of the potential prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with gastric cancer. Int J Biol Markers (1999) 0.77
"Reappearance" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study. J Clin Gastroenterol (1999) 0.77
Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine. Eur J Gastroenterol Hepatol (1997) 0.76
Comparative study of artificial neural networks in the discrimination between benign from malignant gastric cells. Anal Quant Cytol Histol (1997) 0.76
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial. Cancer Chemother Pharmacol (1996) 0.76
Serum levels and alpha1-antitrypsin phenotypes in active pulmonary tuberculosis. Acta Genet Med Gemellol (Roma) (1977) 0.76
A comparative study of three variations of the learning vector quantizer in the discrimination of benign from malignant gastric cells. Cytopathology (1998) 0.76
Watermelon stomach in a patient with vitiligo and systemic lupus erythematosus. Clin Exp Rheumatol (1996) 0.76
C3 phenotypes and peptic ulcer: association of C3 with peptic ulcer but no association of C3 with Helicobacter pylori. Scand J Gastroenterol (1999) 0.75
Comment on: McClung JA, Naseer N, Saleem M et al (2005) circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c. Diabetologia 48:345-350. Diabetologia (2005) 0.75
Collagenous colitis in Greece. Gut (1987) 0.75
Cancer of the stomach after gastric surgery. Br Med J (Clin Res Ed) (1983) 0.75
Letter: Nodular vasculitis of tuberculous origin in an elderly woman. Br Med J (1976) 0.75
Nitroimidazoles for H.pylori eradication. Aliment Pharmacol Ther (1999) 0.75
AL-type amyloidosis presenting with rapidly deteriorating liver involvement. J Clin Gastroenterol (1997) 0.75
Is premedication necessary in diagnostic endoscopy of the upper gastrointestinal tract? Endoscopy (1991) 0.75
Diagnosis of Helicobacter pylori infection with a stool assay: is it useful after eradication treatment? Am J Gastroenterol (2001) 0.75
Colonic polyps found on flexible sigmoidoscopy: a retrospective study. J Clin Gastroenterol (1993) 0.75
Ascaris lumbricoides diagnosed through upper gastrointestinal endoscopy. J Clin Gastroenterol (1997) 0.75
Serum haptoglobin phenotypes and duodenal ulcer. Acta Genet Med Gemellol (Roma) (1977) 0.75
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up. J Clin Gastroenterol (1995) 0.75
The red cell acid phosphatase polymorphism in Greek b-thalassemia patients. Acta Genet Med Gemellol (Roma) (1975) 0.75
Intraluminal duodenal diverticulum. Ital J Gastroenterol (1994) 0.75
Budd-Chiari syndrome in the context of antiphospholipid syndrome: diagnostic and therapeutic implications. Lupus (1995) 0.75
Distribution of Gm and Inv factors in two samples of the Greek population. Acta Genet Med Gemellol (Roma) (1975) 0.75
Treatment of solitary rectal ulcer syndrome with sucralfate enema. Gastrointest Endosc (1989) 0.75
Postoperative pseudomembranous colitis associated with ampicillin therapy. Int Surg (1981) 0.75
Ranitidine and antacids in the prevention of duodenal ulcer relapse in Greece. Hepatogastroenterology (1992) 0.75
Carcinoid of the ampulla of Vater: presentation of a new case. Int Surg (2000) 0.75
Liver fascioliasis, a "mysterious" disease. Report of a case. Acta Hepatogastroenterol (Stuttg) (1977) 0.75
Serum Gm system in liver cirrhosis and hepatoma. Hum Genet (1980) 0.75
Serum protein groups (Hp, GC, C3) in patients with gastric carcinoma. Hum Hered (1992) 0.75
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. Eur J Gastroenterol Hepatol (1997) 0.75
Symptomatic peptic ulcer (PU): is there any seasonal variation? An endoscopic retrospective study. J Clin Gastroenterol (1995) 0.75
Reversed hemagglutination test for the detection of Australia antigen. Transfusion (1976) 0.75
[Relationship between primary carcinoma of the liver and Australia antigen or anti-Australia HB antigen in Greece]. Nouv Presse Med (1977) 0.75
Henoch-Schönlein purpura associated with Campylobacter enterocolitis. J Clin Gastroenterol (1999) 0.75